APA

Horton J., Mittelman A., Taylor S. G., Jurkowitz L., Bennett J. M., Ezdinli E., Colsky J. & Hanley J. A. (19751028). Phase II trials with procarbazine (NSC-77213), streptozotocin (NSC-85998), 6-THIOGUANINE (NSC-752), and CCNU (NSC-79037) in patients with metastatic cancer of the large bowel. : Cancer chemotherapy reports.

Chicago

Horton J, Mittelman A, Taylor S G, Jurkowitz L, Bennett J M, Ezdinli E, Colsky J and Hanley J A. 19751028. Phase II trials with procarbazine (NSC-77213), streptozotocin (NSC-85998), 6-THIOGUANINE (NSC-752), and CCNU (NSC-79037) in patients with metastatic cancer of the large bowel. : Cancer chemotherapy reports.

Harvard

Horton J., Mittelman A., Taylor S. G., Jurkowitz L., Bennett J. M., Ezdinli E., Colsky J. and Hanley J. A. (19751028). Phase II trials with procarbazine (NSC-77213), streptozotocin (NSC-85998), 6-THIOGUANINE (NSC-752), and CCNU (NSC-79037) in patients with metastatic cancer of the large bowel. : Cancer chemotherapy reports.

MLA

Horton J, Mittelman A, Taylor S G, Jurkowitz L, Bennett J M, Ezdinli E, Colsky J and Hanley J A. Phase II trials with procarbazine (NSC-77213), streptozotocin (NSC-85998), 6-THIOGUANINE (NSC-752), and CCNU (NSC-79037) in patients with metastatic cancer of the large bowel. : Cancer chemotherapy reports. 19751028.